Vaginal micronised progesterone soft gel capsule for the treatment of threatened miscarriage

Description

In this Product Explainer, Professor of Obstetrics & Gynaecology, William Ledger explains the role of vaginal micronised progesterone, including the indication, safety profile, clinical trial background and guidelines for use for the treatment and management of threatened miscarriage (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Samantha Hocking

A/Prof Samantha Hocking

New Diagnostic Criteria for Obesity

Prof Rukshen Weerasooriya

Prof Rukshen Weerasooriya

Fatal Arrhythmias – The Patterns GPs Don’t Want to Miss

Dr Rupert Hinds

Dr Rupert Hinds

Infant Allergy Cases

Prof Andrew Sindone

Prof Andrew Sindone

How to Use the BNP Test in General Practice

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof William Ledger

expert

Prof William Ledger

Gynaecologist; Royal Hospital for Women, UNSW

Date published: 8 August 2023